<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03996382</url>
  </required_header>
  <id_info>
    <org_study_id>1-10-72-330-18</org_study_id>
    <nct_id>NCT03996382</nct_id>
  </id_info>
  <brief_title>Prevalence of Wild Type Transthyretin Cardiac Amyloidosis in Patients Operated for Idiopathic Carpal Tunnel Syndrome</brief_title>
  <official_title>Prevalence of Wild Type Transthyretin Cardiac Amyloidosis in Patients Operated for Idiopathic Carpal Tunnel Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital Skejby</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Regional Hospital Holstebro</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aarhus University Hospital Skejby</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Wild-type transthyretin cardiac amyloidosis is an underdiagnosed depository disease in which
      fibril monomers of misfolded amyloid protein accumulates in various tissues, including the
      heart, and cause tissue dysfunction.

      Before onset of cardiac symptoms, many patients will have undergone surgery for idiopathic
      carpal tunnel syndrome since the protein also deposits in the transversal carpal ligament of
      the hand.

      This study investigates patients previously operated for idiopathic carpal tunnel syndrome to
      determine if they display signs and symptoms of cardiac amyloidosis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 17, 2019</start_date>
  <completion_date type="Anticipated">February 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of cardiac amyloidosis.</measure>
    <time_frame>Through study completion, an average of 2 years.</time_frame>
    <description>The prevalence of cardiac amyloidosis among patients previously operated for ipiopathic carpal tunnel syndrome.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Amyloidosis Cardiac</condition>
  <condition>Carpal Tunnel Syndrome</condition>
  <arm_group>
    <arm_group_label>Suspicion of cardiac amyloidosis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients who display signs of cardiac amyloidosis will be referred for further diagnosis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>DPD Scintigraphy</intervention_name>
    <description>Confirms/Refutes diagnosis of cardiac amyloidosis.</description>
    <arm_group_label>Suspicion of cardiac amyloidosis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients above sixty years of age previously operated for idiopathic carpal tunnel
             syndrome within the Region of Central Denmark (Region Midtjylland) the last five
             years.

          -  Informed written and verbal consent

        Exclusion Criteria:

          -  Operation by different indication such as

               -  Fracture

               -  Ganglion

               -  Tumors

               -  Osteophytes

               -  Rheumatoid Arthritis

               -  Persistent medial artery

               -  Metabolic causes

          -  Alcoholism

          -  Hyperthyroidism

          -  Myxedema

               -  Hereditary Cardiac Amyloidosis

               -  Known WT ATTR

               -  AL Amyloidosis

               -  Myelomatosis

               -  MGUS and Morbus Waldenstr√∂m
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Steen Hvitfeldt Poulsen</last_name>
    <phone>+4530922309</phone>
    <email>steepoul@rm.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bertil Ladefoged</last_name>
    <phone>+4540927245</phone>
    <email>201307379@post.au.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Heart Disease</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steen Hvitfeldt Poulsen, Professor</last_name>
      <phone>+4530922309</phone>
      <email>steepoul@rm.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>June 17, 2019</study_first_submitted>
  <study_first_submitted_qc>June 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 24, 2019</study_first_posted>
  <last_update_submitted>February 17, 2020</last_update_submitted>
  <last_update_submitted_qc>February 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aarhus University Hospital Skejby</investigator_affiliation>
    <investigator_full_name>Steen Hvitfeldt Poulsen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
    <mesh_term>Amyloidosis</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

